Oncaspar 3,750 unit/5 ML vial 5ML
Ended Awarded
- Contract number
- SPE2DX25F6AAJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $27,351
Award facts
- Contract value 100% obligated
- $27,351.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27.4K by the Defense Logistics Agency's Medical Supply Chain for 3,750 units of Oncaspar 5 milliliter vials. The contract is firm fixed-price with no set-aside designation and an ultimate completion date of July 28, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a ceiling value of approximately $500 million through November 2026 and enables the government to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities worldwide.
Oncaspar is a critical oncology medication used in the treatment of acute lymphoblastic leukemia, making this delivery order part of the Department of Defense's broader pharmaceutical supply chain supporting medical needs across military health facilities. DMS Pharmaceutical Group has established itself as a significant federal pharmaceutical supplier, with a robust portfolio of delivery orders covering prescription medications, biologics, vaccines, and specialized pharmaceutical products. The company's consistent success in federal procurement—without relying on specific set-aside programs beyond its woman-owned small business status—reflects its competitive positioning in the military healthcare supply market.
Quick answers
Who was awarded contract SPE2DX25F6AAJ?
SPE2DX25F6AAJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 7, 2025.
How much is contract SPE2DX25F6AAJ worth?
The government has obligated $27,351 on SPE2DX25F6AAJ.
Is contract SPE2DX25F6AAJ an order under another contract?
Yes. SPE2DX25F6AAJ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AAJ competed?
The extent of competition for SPE2DX25F6AAJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award